How Prioritizing Health is a Prescription for US Prosperity

How Prioritizing Health is a Prescription for US Prosperity

McKinsey & Company

October 5, 2020

Is healthcare a cost to be contained or an investment that yields a measurable return? Health has not typically been part of discussions about economic growth. Then came COVID-19, which may shave as much as 11% off US real GDP growth this year. Consultants at McKinsey estimate premature deaths and lost productivity of American workers costs the country $3.2 trillion. Mental illnesses and substance abuse disorders are among the top five most expensive diseases. For every $1 invested in improving the health of the population, the US stands to gain almost $4 in economic impact, McKinsey predicts. But the “health benefits and the economic upside we calculate will not be possible without fundamental changes in not just where and how healthcare is delivered today, but also in how we build communities that help individuals grow up, work and age in healthy ways,” the consultants say.

Read more here.